BioWorld

April 3, 2008

View Archived Issues

Medarex Shares Take Hit Amid Pfizer's Halted Melanoma Trial

Medarex shares plummeted Wednesday as partner Pfizer Inc. unexpectedly halted a Phase III trial of potential melanoma treatment tremelimumab. (BioWorld Today) Read More

Trial Data Could Prompt ISTA to Tweak Xibrom Formulations

Read More

Papers Agree on Lung Cancer Risk Genes, Disagree on Why

Read More

FDA Panel Supports Use of Noninferiority Studies for CAP

Read More

Genta Cutting Staff, Selling Ganite in Wake of Rejection

Read More

Generex Raising $20.7M Privately For Oral-lyn Insulin Spray Trials

Read More

Other News To Note

Read More

Clinic Roundup

Read More